| For: | Curto A, Iamello RG, Lynch EN, Galli A. Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies. World J Clin Cases 2025; 13(30): 109028 [PMID: 41113084 DOI: 10.12998/wjcc.v13.i30.109028] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v13/i30/109028.htm |
| Number | Citing Articles |
| 1 |
Mandea Matei, Gheorghe Liliana Simona. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]. 2026; doi: 10.5772/intechopen.1016072
|
| 2 |
Abdellatif Bouayad. Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions. World Journal of Clinical Cases 2026; 14(5): 115814 doi: 10.12998/wjcc.v14.i5.115814
|
| 3 |
Mandea Matei, Gheorghe Liliana Simona. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]. 2026; doi: 10.5772/intechopen.1016073
|
| 4 |
Xavier Palomer, Ricardo Rodríguez-Calvo, Sandra García-Mateo, Walter Wahli, Manuel Vázquez-Carrera. The emerging role of PPARs in primary biliary cholangitis. Trends in Molecular Medicine 2026; doi: 10.1016/j.molmed.2026.05.008
|